AIDS Therapies (Protease Inhibitors)
"HIV-1 Protease Inhibitors - A Review for Clinicians."
Published in AIDS Weekly, February 10th, 1997
According to the authors' abstract of an article published in JAMA - Journal of the American Medical Association, "Objective: The clinical care of people infected with human immunodeficiency virus (HIV) has been substantially affected by the introduction of HIV-specific protease inhibitors (PIs). The 4 PIs available are saquinavir mesylate, ritonavir, indinavir sulfate, and nelfinavir mesylate. Comparison studies have not been reported; therefore, an assessment of the available data to aid clinicians and patients in choosing appropriate treatment will be presented. Data Sources: A systematic review of peer-reviewed publications, abstracts from national and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-02-10)
More Articles from AIDS Weekly
- Retrovirus Conference
AIDS Organizations Call for National Conference Expansion - Conference Coverage (Retrovirus)
Canarypox Prime/Boost Approach Ready for Advanced Trials - Conference Coverage (Retrovirus)
Even at Low Levels, HIV in Blood is Bad News - Conference Coverage (Retrovirus)
Gene Types Linked to AIDS Progression - Conference Coverage (Retrovirus)
HIV Lurks in Lymph Nodes During Triple Therapy - Conference Coverage (Retrovirus)
HIV, Apoptosis Reduced in Mucosa During AIDS Therapy - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
